Epidemiology of respiratory infections during the COVID-19 pandemic

N Principi, G Autore, G Ramundo, S Esposito - Viruses, 2023 - mdpi.com
To face the COVID-19 outbreak, a wide range of non-pharmaceutical interventions (NPIs)
aimed at limiting the spread of the virus in communities, such as mask-wearing, hand …

Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis

B Wei, R Zhang, H Zeng, L Wu, R He… - Expert Review of Anti …, 2023 - Taylor & Francis
Background We aimed to assess the impact of antiviral drugs (fluvoxamine, remdesivir,
lopinavir/ritonavir (LPV/r), molnupiravir, andnirmatrelvir/ritonavir (NRV/r)) on health care …

Unveiling patenting strategies of therapeutics and vaccines: evergreening in the context of COVID-19 pandemic

ML Bacigalupo, MF Pignataro, CT Scopel… - Frontiers in …, 2023 - frontiersin.org
In the pharmaceutical sector, evergreening is considered a range of practices applied to
extend monopoly protection on existing products. Filing several patent applications related …

Molecular targets in SARS-CoV-2 infection: an update on repurposed drug candidates

D Rahmani, A Jafari, P Kesharwani… - Pathology-Research and …, 2024 - Elsevier
The 2019 widespread contagion of the human coronavirus novel type (SARS-CoV-2) led to
a pandemic declaration by the World Health Organization. A daily increase in patient …

Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity

RA Akasov, OE Chepikova, TN Pallaeva… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Background Riboflavin (vitamin B2) is one of the most important water-soluble vitamins and
a coenzyme involved in many biochemical processes. It has previously been shown that …

Recent developments in the therapeutics of SARS-CoV-2 infection

P Nagu, A Parashar, P Sharma, V Mehta - One Health Bulletin, 2024 - journals.lww.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmittable
respiratory virus that causes COVID-19 disease. Since its emergence in the early 2000s …

OPEN ACCESS EDITED BY

MA Gagnon, R Lajmanovich, A Massarini… - Current Priorities in …, 2024 - books.google.com
Since December 2019, the world has witnessed the beginning of the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, with 769.4 million …

Utilizing Omics Technologies and Machine Learning to Improve Predictive Toxicology

A Son, J Park, W Kim, Y Yoon, S Lee, H Kim - 2024 - preprints.org
The topic of predictive toxicology has been greatly influenced by recent progress in
comprehending drug toxicity processes and enhancing medication development. The …